It has been shown that MED23 knock‐down promotes tumorigenicity and inhibits apoptosis through a decrease of BAX expression, yet conversely, MED24 knock‐down in breast carcinoma cells lead to diminished cell proliferation and DNA synthesis.46 Here, MED23 is linked to breast carcinoma.